Public dataset
Recorded source agreement and disagreement
Show whether sources print one normalized reading, have incompatible units, lack structured comparison context, or contain a context-matched numeric difference.
- Public rows
- 1,681
- Generated
- Schema version
- source-consensus/2
Coverage
What this run contains
- Compared medicine fields
- 1,681
- Agree
- 1,282
- Differ
- 0
- Not comparable
- 12
- Insufficient context
- 387
- Fields represented
- 5
- bioavailability, halfLife, proteinBinding, tMax, volumeOfDistribution
Method
How the rows were made
- Deterministic rules normalize recorded pharmacokinetic readings and compare only like-for-like values.
- One normalized printed reading may be agree even when clinical context was not extracted; this reports printed-reading agreement only.
- Distinct readings may differ only when their units and denominators are comparable and one matching, non-placeholder population/formulation context was structurally extracted. Otherwise they are insufficient_context.
- not_comparable preserves incompatible units or denominators instead of guessing. insufficient_context preserves missing or non-matching structured context instead of manufacturing agreement or disagreement.
- The agreement rate describes the distribution of recorded source readings; it is not a probability that a value is true.
- Every distinct printed reading retains its unit, population context, source count, and complete source records. The API paginates field rows, never child readings or sources.
- documentsExamined is every matching single-substance archive document inspected for that medicine. The generator has no document, reading, or source ceiling, so there is no hidden available-versus-retained remainder.
Limits
Read these before using a row
- Current label parsing does not structurally extract population or formulation context. Distinct otherwise-comparable readings are therefore insufficient_context, never differ; agree may mean printed-reading agreement only. Source records are complete but are not independent-experiment counts.
- The current deterministic parser does not structurally extract population or formulation context from these sentences. It records that context as unknown and cannot publish distinct same-unit readings as differ.
- Neither reading is marked wrong. Population, formulation, route, and other unextracted context may explain the printed difference.
- Only the recorded fields and source documents in this snapshot are compared.
- A source count is the number of retained source records in the row, not a count of independent experiments.
Provenance
Source examples
abacavir · bioavailability · agree
15 documents examined; 83% (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:5676d391-f9a4-44be-9604-954b3d8d0e2b (opens source in a new tab)The geometric mean absolute bioavailability of the tablet was 83%.
alemtuzumab · volumeOfDistribution · not_comparable
2 documents examined; 0.18 L/kg (Unknown: population and formulation context were not structurally extracted from this source sentence.); 14.1 L (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:4f5f7255-7abc-4328-bd1a-ceaf139ef3e0 (opens source in a new tab)Distribution After the last 30 mg dose, the mean volume of distribution at steady-state was 0.18 L/kg (range 0.1 to 0.4 L/kg).
abiraterone · halfLife · insufficient_context
31 documents examined; 12 ± 5 hours (Unknown: population and formulation context were not structurally extracted from this source sentence.); 18 hours (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:c9eb9b46-f847-40a8-802c-a51b40406d5a (opens source in a new tab)Elimination In patients with metastatic CRPC, the mean terminal half-life of abiraterone in plasma (mean ± SD) is 12 ± 5 hours.
Artifact used for this view: data/source-consensus.ndjson. The reader resolves the current run first and uses the checked-in compatibility run only when a current artifact is absent.
Schema
Fields in the public projection
| Field | Type | Meaning |
|---|---|---|
| medicineSlug | string | Stable RNAWiki medicine route key. |
| field | string | Recorded pharmacokinetic field being compared. |
| comparisonState | string | agree (printed-reading agreement), differ (context-matched comparable disjoint values), not_comparable (unit/denominator mismatch), or insufficient_context. Every state remains declared even when its current count is zero. |
| comparisonReasons | string[] | Deterministic codes explaining the state. |
| documentsExamined | number | Recorded source documents considered for the field. |
| sourceCount | number | Recorded source readings represented. |
| agreementRate | number | Share represented by the leading normalized printed-reading group; not a confidence score or clinical agreement probability. |
| readings | consensus-reading[] | Complete, untruncated reading groups. Each keeps the printed display, numeric value when parsed, unit, population context, source count, and every source identity, version/effective date or explicit absence, retrieval date, locator, safe link, and excerpt. |
Reader
Search and filter the rows
Showing 931–940 of 1,681 matching rows. Filters and search terms remain attached when you move between pages or open the API view.
Projected row 931
- Medicine slug
- melphalan
- Compared field
- proteinBinding
- Comparison state
- insufficient_context
- Reason codes
- STRUCTURED_CONTEXT_MISSING
- Documents examined
- 16
- Source count
- 9
- Agreement rate
- 0.777778
- Recorded readings
20%
- Numeric value
- 20
- Unit
- %
- Source records
- 7
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 7 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d4705154-3050-1a5c-950f-e24b51487401 (opens source in a new tab)
Melphalan label
Version not recorded · Effective date not recorded
Serum albumin is the major binding protein, accounting for approximately 40% to 60% of the plasma protein binding, while α1-acid glycoprotein accounts for about 20% of the plasma protein binding.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8edd78a9-d762-4578-a610-28d6595f4bf3 (opens source in a new tab)
Melphalan label
Version not recorded · Effective date not recorded
Serum albumin is the major binding protein, accounting for approximately 40% to 60% of the plasma protein binding, while α 1 -acid glycoprotein accounts for about 20% of the plasma protein binding.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bd5e4db5-8787-4428-2cb6-ef6f8a5e08af (opens source in a new tab)
Melphalan label
Version not recorded · Effective date not recorded
Serum albumin is the major binding protein, accounting for approximately 40% to 60% of the plasma protein binding, while α1-acid glycoprotein accounts for about 20% of the plasma protein binding.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2254450e-4803-b947-e063-6394a90a4624 (opens source in a new tab)
Melphalan label
Version not recorded · Effective date not recorded
Serum albumin is the major binding protein, accounting for approximately 40% to 60% of the plasma protein binding, while α 1 -acid glycoprotein accounts for about 20% of the plasma protein binding.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d99b3865-e0f0-482a-9ec6-da642e5104ea (opens source in a new tab)
Melphalan label
Version not recorded · Effective date not recorded
Serum albumin is the major binding protein, accounting for approximately 40% to 60% of the plasma protein binding, while α 1 -acid glycoprotein accounts for about 20% of the plasma protein binding.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:91948ff9-6070-485b-b4b7-3cb477c1b24c (opens source in a new tab)
Melphalan label
Version not recorded · Effective date not recorded
Serum albumin is the major binding protein, accounting for approximately 40% to 60% of the plasma protein binding, while α 1 -acid glycoprotein accounts for about 20% of the plasma protein binding.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:35f3d9fe-3c2f-4362-9d40-cdab014cac38 (opens source in a new tab)
Melphalan label
Version not recorded · Effective date not recorded
Serum albumin is the major binding protein, accounting for approximately 40% to 60% of the plasma protein binding, while α 1 -acid glycoprotein accounts for about 20% of the plasma protein binding.
50%
- Numeric value
- 50
- Unit
- %
- Source records
- 1
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 1 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:69f55869-dc11-408e-8fc7-47634269a52c (opens source in a new tab)
Melphalan label
Version not recorded · Effective date not recorded
Protein binding of melphalan ranges from approximately 50% to 90%, primarily to serum albumin (40% to 60%) and to a lesser extent to α1-acid glycoprotein (20%).
53%
- Numeric value
- 53
- Unit
- %
- Source records
- 1
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 1 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c23e868a-dc62-2181-5099-76c9226602b2 (opens source in a new tab)
Melphalan label
Version not recorded · Effective date not recorded
The mean melphalan plasma protein binding ranges from 53% to 92% with approximately 30% irreversible (covalent).
Projected row 932
- Medicine slug
- melphalan
- Compared field
- volumeOfDistribution
- Comparison state
- not_comparable
- Reason codes
- DENOMINATOR_MISMATCH
- Documents examined
- 16
- Source count
- 9
- Agreement rate
- 0.888889
- Recorded readings
0.5 L/kg
- Numeric value
- 0.5
- Unit
- L/kg
- Source records
- 8
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 8 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d4705154-3050-1a5c-950f-e24b51487401 (opens source in a new tab)
Melphalan label
Version not recorded · Effective date not recorded
The steady-state volume of distribution of melphalan is 0.5 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8edd78a9-d762-4578-a610-28d6595f4bf3 (opens source in a new tab)
Melphalan label
Version not recorded · Effective date not recorded
The steady-state volume of distribution of melphalan is 0.5 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bd5e4db5-8787-4428-2cb6-ef6f8a5e08af (opens source in a new tab)
Melphalan label
Version not recorded · Effective date not recorded
The steady-state volume of distribution of melphalan is 0.5 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2254450e-4803-b947-e063-6394a90a4624 (opens source in a new tab)
Melphalan label
Version not recorded · Effective date not recorded
The steady-state volume of distribution of melphalan is 0.5 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d99b3865-e0f0-482a-9ec6-da642e5104ea (opens source in a new tab)
Melphalan label
Version not recorded · Effective date not recorded
The steady-state volume of distribution of melphalan is 0.5 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:91948ff9-6070-485b-b4b7-3cb477c1b24c (opens source in a new tab)
Melphalan label
Version not recorded · Effective date not recorded
The steady-state volume of distribution of melphalan is 0.5 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c23e868a-dc62-2181-5099-76c9226602b2 (opens source in a new tab)
Melphalan label
Version not recorded · Effective date not recorded
Distribution The melphalan steady-state volume of distribution is 0.5 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:35f3d9fe-3c2f-4362-9d40-cdab014cac38 (opens source in a new tab)
Melphalan label
Version not recorded · Effective date not recorded
The steady-state volume of distribution of melphalan is 0.5 L/kg.
35.5 to 185.7 L
- Numeric value
- 35.5
- Unit
- L
- Source records
- 1
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 1 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:69f55869-dc11-408e-8fc7-47634269a52c (opens source in a new tab)
Melphalan label
Version not recorded · Effective date not recorded
Distribution The volume of distribution of melphalan ranges from approximately 35.5 to 185.7 L/m 2 .
Projected row 933
- Medicine slug
- memantine
- Compared field
- bioavailability
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 67
- Source count
- 67
- Agreement rate
- 1
- Recorded readings
20%
- Numeric value
- 20
- Unit
- %
- Source records
- 67
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 67 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:421f6478-09df-49d3-a7c4-52814b4aa90e (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine hydrochloride and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a5dcc0e7-761f-4294-bb48-e5ee4a1e2f67 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine hydrochloride and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:62e32b0b-1eb2-424d-bfd2-d27ef27d35f3 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d1f97615-e888-421e-b50a-95a87a1965ff (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine hydrochloride and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:910827aa-5320-446c-8f66-3f17c0ee36d9 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine hydrochloride and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5c8a168d-aef5-4ac7-b8c1-3812a8c228ab (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine hydrochloride and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f73e0df0-4af4-42f1-bde6-3cccb47ca378 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, co-administration of memantine hydrochloride and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a7b76864-6de7-45f6-be5b-5ecfca811627 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine hydrochloride and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0c7fd6ab-2ce5-4110-b6e6-9103c8da0765 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:afc07196-be28-4521-afc0-d4aa5b6fd46d (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine hydrochloride and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:72973b46-f307-4a9e-8fb1-ad2cbccfd736 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine hydrochloride and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a71e2482-5266-d03e-8b36-862afe78c9a4 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine hydrochloride and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:be919d34-e9f4-49c8-8145-2dcafb7cb88c (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine hydrochloride and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7a40ed9d-8853-b616-ff47-0c7b0fd28959 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine hydrochloride and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6906b0b4-1944-40f0-844a-e0db72ba4675 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ceb733fa-4526-4b76-ab6a-bd4c5638afff (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine hydrochloride and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2bd37a6f-bdeb-42c2-9f03-fbf06b45cfe0 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine hydrochloride and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f05e381f-850d-42ea-9dd8-6d1f8dac4f62 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine hydrochloride and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9b4e3c54-c001-47cc-bc3a-7d4bf25ccfaf (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine hydrochloride and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:becb09dc-174d-4817-88d4-f38c8adcd309 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine hydrochloride and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:54a12ddf-306b-4eb7-a7c3-c7b58df3b372 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine hydrochloride and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:eac265e6-6ea4-4368-acff-2efe6a8dd40a (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:24290655-47f3-4042-a977-a832c5161d2c (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:65c9e7bc-71f0-4113-8de1-4fcaa591735f (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine hydrochloride and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:292671f2-f221-4a3d-a110-a266a9527e04 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine hydrochloride and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3662b11a-354a-b683-e063-6394a90a0086 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine hydrochloride and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fac8c59b-5bf5-478e-8223-a5ecaa400625 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine hydrochloride and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4d48c958-b606-4427-8502-53450718eefb (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine hydrochloride and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:304a3059-4f7f-4ec4-839d-86492bb5e07b (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine hydrochloride and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e5754973-e73b-4a25-abb4-80f91880f018 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine hydrochloride and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:47e4a696-fe2a-c905-e063-6294a90a7415 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine hydrochloride and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d1963395-3cf7-4433-bf2c-06295bb1c5b0 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine hydrochloride and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:66db6d61-cf1d-46ca-a645-19e9a20f4617 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine hydrochloride and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2d54be77-75b2-76b3-e063-6294a90a0cc0 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine hydrochloride and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a282fbed-8304-458e-a0e9-5eaccc95339b (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d0a5e0fc-04e3-417d-bef3-9b309ff71597 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine hydrochloride and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a74050c4-5a37-4fa1-85d9-85831525cfeb (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1b4a0162-9cb4-4ba6-8c02-95c2955734ae (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine hydrochloride and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c8f5c20b-4573-44c5-89fc-4da11b2e1fe1 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of Memantine HCl and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:42f0a9f2-4aa4-46fb-bc24-d3df843bb906 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine hydrochloride and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2fdf0b2b-0337-472d-83ec-075c17c9b0d0 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine hydrochloride and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:054069b5-7aac-4106-821f-ebf7fd531b4f (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, co-administration of memantine hydrochloride and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:11d27c75-fdc0-f9da-e063-6394a90ac6b0 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine hydrochloride and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b86c0f6e-480b-40e7-aa4d-21bd0659101d (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine hydrochloride and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1289db0e-5179-d157-e063-6294a90ab758 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine hydrochloride and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bf395152-2885-4633-bf3f-2da46e7b79f1 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine hydrochloride and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:30b8b982-db74-7cf4-e063-6394a90a3a6b (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine hydrochloride and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f2b7538d-8ca1-4ac7-a172-d268e2fa9a52 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, co-administration of memantine and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:989fa756-7d70-4ea7-bb5e-f4395e48589d (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine hydrochloride and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d1c2ec99-7183-46e3-a96e-4f23e20b8b06 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine hydrochloride and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ff74edcb-d7ed-4b70-8f22-4cb5ccc58f90 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine hydrochloride and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0ad2246a-ffa0-43a0-8094-58279d3e3a74 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine hydrochloride and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8bd5b908-f46a-4ced-9408-45984d716149 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine hydrochloride and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4076d3ef-d0a9-96c5-1a15-812c1e42929c (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c343b0c5-3bfc-4b94-9483-a56924f6dcdb (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine hydrochloride tablets, USP and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f6ce7cca-d245-44f2-986c-2a8d85dbb5fb (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d0839a2d-35f1-1f14-e053-2995a90ad549 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine hydrochloride and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cbfd9d95-f50b-45ff-9857-9f1712c45e56 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine hydrochloride and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ca619439-f4ca-43f1-9261-9aa2b6dc7450 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine hydrochloride and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:af2b73da-1be4-4b7f-929b-acb3b9a10f78 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine hydrochloride and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2ac7d23c-5f9f-4ffc-ae01-d7099a8a7929 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine hydrochloride and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9cfddd01-6e1d-4ee0-9310-3fb371724e3d (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine hydrochloride and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2b2dcd54-47e0-494b-85d2-c28c3adbe737 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c8f96b24-de66-4a17-b798-42b42a25e84c (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine hydrochloride and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6e0ade9e-b721-4701-bcb7-de464e19e707 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:30b4d5c4-0a31-c385-e063-6394a90adbce (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine hydrochloride and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dcbdb62a-a4e2-4058-b73c-46005f2a5d51 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, coadministration of memantine hydrochloride and HCTZ/TA did not affect the bioavailability of either memantine or TA, and the bioavailability of HCTZ decreased by 20%.
Projected row 934
- Medicine slug
- memantine
- Compared field
- halfLife
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 67
- Source count
- 42
- Agreement rate
- 1
- Recorded readings
60 to 80 hours
- Numeric value
- 60
- Unit
- hours
- Source records
- 42
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 42 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:421f6478-09df-49d3-a7c4-52814b4aa90e (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Elimination Memantine is excreted predominantly (about 48%) unchanged in urine and has a terminal elimination half-life of about 60 to 80 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a5dcc0e7-761f-4294-bb48-e5ee4a1e2f67 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Elimination Memantine is excreted predominantly (about 48%) unchanged in urine and has a terminal elimination half-life of about 60 to 80 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:62e32b0b-1eb2-424d-bfd2-d27ef27d35f3 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
It is excreted predominantly unchanged in urine and has a terminal elimination half-life of about 60-80 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d1f97615-e888-421e-b50a-95a87a1965ff (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Elimination Memantine is excreted predominantly (about 48%) unchanged in urine and has a terminal elimination half-life of about 60-80 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5c8a168d-aef5-4ac7-b8c1-3812a8c228ab (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Elimination Memantine is excreted predominantly (about 48%) unchanged in urine and has a terminal elimination half-life of about 60 to 80 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f73e0df0-4af4-42f1-bde6-3cccb47ca378 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Elimination Memantine is excreted predominantly (about 48%) unchanged in urine and has a terminal elimination half-life of about 60 to 80 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a7b76864-6de7-45f6-be5b-5ecfca811627 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Elimination Memantine is excreted predominantly (about 48%) unchanged in urine and has a terminal elimination half-life of about 60-80 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0c7fd6ab-2ce5-4110-b6e6-9103c8da0765 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
It is excreted predominantly unchanged in urine and has a terminal elimination half-life of about 60-80 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:afc07196-be28-4521-afc0-d4aa5b6fd46d (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Elimination Memantine is excreted predominantly (about 48%) unchanged in urine and has a terminal elimination half-life of about 60-80 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a71e2482-5266-d03e-8b36-862afe78c9a4 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Elimination Memantine is excreted predominantly (about 48%) unchanged in urine and has a terminal elimination half-life of about 60 to 80 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7a40ed9d-8853-b616-ff47-0c7b0fd28959 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Elimination Memantine is excreted predominantly (about 48%) unchanged in urine and has a terminal elimination half-life of about 60 to 80 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ceb733fa-4526-4b76-ab6a-bd4c5638afff (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Elimination Memantine is excreted predominantly (about 48%) unchanged in urine and has a terminal elimination half-life of about 60 to 80 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:becb09dc-174d-4817-88d4-f38c8adcd309 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Elimination Memantine is excreted predominantly (about 48%) unchanged in urine and has a terminal elimination half-life of about 60-80 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:eac265e6-6ea4-4368-acff-2efe6a8dd40a (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Excretion Memantine is excreted predominantly unchanged in the urine and has a terminal elimination half-life of about 60 to 80 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:24290655-47f3-4042-a977-a832c5161d2c (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
It is excreted predominantly unchanged in urine and has a terminal elimination half-life of about 60 to 80 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:65c9e7bc-71f0-4113-8de1-4fcaa591735f (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Elimination Memantine is excreted predominantly (about 48%) unchanged in urine and has a terminal elimination half-life of about 60 to 80 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:292671f2-f221-4a3d-a110-a266a9527e04 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Elimination Memantine is excreted predominantly (about 48%) unchanged in urine and has a terminal elimination half-life of about 60-80 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:304a3059-4f7f-4ec4-839d-86492bb5e07b (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Elimination Memantine is excreted predominantly (about 48%) unchanged in urine and has a terminal elimination half-life of about 60 to 80 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:47e4a696-fe2a-c905-e063-6294a90a7415 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Elimination Memantine is excreted predominantly (about 48%) unchanged in urine and has a terminal elimination half-life of about 60-80 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:66db6d61-cf1d-46ca-a645-19e9a20f4617 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Elimination Memantine is excreted predominantly (about 48%) unchanged in urine and has a terminal elimination half-life of about 60-80 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a282fbed-8304-458e-a0e9-5eaccc95339b (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
It is excreted predominantly unchanged in urine and has a terminal elimination half-life of about 60-80 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d0a5e0fc-04e3-417d-bef3-9b309ff71597 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Elimination Memantine is excreted predominantly (about 48%) unchanged in urine and has a terminal elimination half-life of about 60 to 80 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a74050c4-5a37-4fa1-85d9-85831525cfeb (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
It is excreted predominantly unchanged in urine and has a terminal elimination half-life of about 60 to 80 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1b4a0162-9cb4-4ba6-8c02-95c2955734ae (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Elimination Memantine is excreted predominantly (about 48%) unchanged in urine and has a terminal elimination half-life of about 60 to 80 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:42f0a9f2-4aa4-46fb-bc24-d3df843bb906 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Elimination Memantine is excreted predominantly (about 48%) unchanged in urine and has a terminal elimination half-life of about 60 to 80 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2fdf0b2b-0337-472d-83ec-075c17c9b0d0 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Elimination Memantine is excreted predominantly (about 48%) unchanged in urine and has a terminal elimination half-life of about 60-80 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:054069b5-7aac-4106-821f-ebf7fd531b4f (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Elimination Memantine is excreted predominantly (about 48%) unchanged in urine and has a terminal elimination half-life of about 60 to 80 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:11d27c75-fdc0-f9da-e063-6394a90ac6b0 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Elimination Memantine is excreted predominantly (about 48%) unchanged in urine and has a terminal elimination half-life of about 60-80 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b86c0f6e-480b-40e7-aa4d-21bd0659101d (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Elimination Memantine is excreted predominantly (about 48%) unchanged in urine and has a terminal elimination half-life of about 60 to 80 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1289db0e-5179-d157-e063-6294a90ab758 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Elimination Memantine is excreted predominantly (about 48%) unchanged in urine and has a terminal elimination half-life of about 60-80 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:30b8b982-db74-7cf4-e063-6394a90a3a6b (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Elimination Memantine is excreted predominantly (about 48%) unchanged in urine and has a terminal elimination half-life of about 60-80 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f2b7538d-8ca1-4ac7-a172-d268e2fa9a52 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
It is excreted predominantly unchanged in urine and has a terminal elimination half-life of about 60-80 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:989fa756-7d70-4ea7-bb5e-f4395e48589d (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Elimination Memantine is excreted predominantly (about 48%) unchanged in urine and has a terminal elimination half-life of about 60-80 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d1c2ec99-7183-46e3-a96e-4f23e20b8b06 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Elimination Memantine is excreted predominantly (about 48%) unchanged in urine and has a terminal elimination half-life of about 60-80 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ff74edcb-d7ed-4b70-8f22-4cb5ccc58f90 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Elimination Memantine is excreted predominantly (about 48%) unchanged in urine and has a terminal elimination half-life of about 60-80 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4076d3ef-d0a9-96c5-1a15-812c1e42929c (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Elimination Memantine is excreted predominantly (about 48%) unchanged in urine and has a terminal elimination half-life of about 60 to 80 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c343b0c5-3bfc-4b94-9483-a56924f6dcdb (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Elimination Memantine is excreted predominantly (about 48%) unchanged in urine and has a terminal elimination half-life of about 60-80 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f6ce7cca-d245-44f2-986c-2a8d85dbb5fb (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
It is excreted predominantly unchanged in urine and has a terminal elimination half-life of about 60 to 80 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ca619439-f4ca-43f1-9261-9aa2b6dc7450 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Elimination Memantine is excreted predominantly (about 48%) unchanged in urine and has a terminal elimination half-life of about 60-80 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:af2b73da-1be4-4b7f-929b-acb3b9a10f78 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Elimination Memantine is excreted predominantly (about 48%) unchanged in urine and has a terminal elimination half-life of about 60 to 80 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2b2dcd54-47e0-494b-85d2-c28c3adbe737 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
It is excreted predominantly unchanged in urine and has a terminal elimination half-life of about 60 to 80 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:30b4d5c4-0a31-c385-e063-6394a90adbce (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Elimination Memantine is excreted predominantly (about 48%) unchanged in urine and has a terminal elimination half-life of about 60 to 80 hours.
Projected row 935
- Medicine slug
- memantine
- Compared field
- proteinBinding
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 67
- Source count
- 67
- Agreement rate
- 1
- Recorded readings
45%
- Numeric value
- 45
- Unit
- %
- Source records
- 67
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 67 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:421f6478-09df-49d3-a7c4-52814b4aa90e (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to 11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a5dcc0e7-761f-4294-bb48-e5ee4a1e2f67 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to 11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:62e32b0b-1eb2-424d-bfd2-d27ef27d35f3 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9-11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d1f97615-e888-421e-b50a-95a87a1965ff (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9-11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:910827aa-5320-446c-8f66-3f17c0ee36d9 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to 11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5c8a168d-aef5-4ac7-b8c1-3812a8c228ab (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to 11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f73e0df0-4af4-42f1-bde6-3cccb47ca378 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 L/kg to 11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a7b76864-6de7-45f6-be5b-5ecfca811627 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9-11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0c7fd6ab-2ce5-4110-b6e6-9103c8da0765 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9-11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:afc07196-be28-4521-afc0-d4aa5b6fd46d (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9-11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:72973b46-f307-4a9e-8fb1-ad2cbccfd736 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9-11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a71e2482-5266-d03e-8b36-862afe78c9a4 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to 11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:be919d34-e9f4-49c8-8145-2dcafb7cb88c (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7a40ed9d-8853-b616-ff47-0c7b0fd28959 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to 11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6906b0b4-1944-40f0-844a-e0db72ba4675 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to 11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ceb733fa-4526-4b76-ab6a-bd4c5638afff (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to 11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2bd37a6f-bdeb-42c2-9f03-fbf06b45cfe0 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f05e381f-850d-42ea-9dd8-6d1f8dac4f62 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9b4e3c54-c001-47cc-bc3a-7d4bf25ccfaf (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to 11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:becb09dc-174d-4817-88d4-f38c8adcd309 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9-11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:54a12ddf-306b-4eb7-a7c3-c7b58df3b372 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:eac265e6-6ea4-4368-acff-2efe6a8dd40a (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to 11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:24290655-47f3-4042-a977-a832c5161d2c (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to 11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:65c9e7bc-71f0-4113-8de1-4fcaa591735f (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to 11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:292671f2-f221-4a3d-a110-a266a9527e04 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9-11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3662b11a-354a-b683-e063-6394a90a0086 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fac8c59b-5bf5-478e-8223-a5ecaa400625 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4d48c958-b606-4427-8502-53450718eefb (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to 11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:304a3059-4f7f-4ec4-839d-86492bb5e07b (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to 11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e5754973-e73b-4a25-abb4-80f91880f018 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9-11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:47e4a696-fe2a-c905-e063-6294a90a7415 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9-11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d1963395-3cf7-4433-bf2c-06295bb1c5b0 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to 11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:66db6d61-cf1d-46ca-a645-19e9a20f4617 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9-11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2d54be77-75b2-76b3-e063-6294a90a0cc0 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a282fbed-8304-458e-a0e9-5eaccc95339b (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9-11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d0a5e0fc-04e3-417d-bef3-9b309ff71597 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to 11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a74050c4-5a37-4fa1-85d9-85831525cfeb (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to 11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1b4a0162-9cb4-4ba6-8c02-95c2955734ae (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to 11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c8f5c20b-4573-44c5-89fc-4da11b2e1fe1 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9-11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:42f0a9f2-4aa4-46fb-bc24-d3df843bb906 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to 11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2fdf0b2b-0337-472d-83ec-075c17c9b0d0 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9-11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:054069b5-7aac-4106-821f-ebf7fd531b4f (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to 11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:11d27c75-fdc0-f9da-e063-6394a90ac6b0 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9-11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b86c0f6e-480b-40e7-aa4d-21bd0659101d (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to 11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1289db0e-5179-d157-e063-6294a90ab758 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9-11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bf395152-2885-4633-bf3f-2da46e7b79f1 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:30b8b982-db74-7cf4-e063-6394a90a3a6b (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9-11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f2b7538d-8ca1-4ac7-a172-d268e2fa9a52 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to 11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:989fa756-7d70-4ea7-bb5e-f4395e48589d (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9-11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d1c2ec99-7183-46e3-a96e-4f23e20b8b06 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9-11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ff74edcb-d7ed-4b70-8f22-4cb5ccc58f90 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9-11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0ad2246a-ffa0-43a0-8094-58279d3e3a74 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8bd5b908-f46a-4ced-9408-45984d716149 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4076d3ef-d0a9-96c5-1a15-812c1e42929c (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to 11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c343b0c5-3bfc-4b94-9483-a56924f6dcdb (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9-11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f6ce7cca-d245-44f2-986c-2a8d85dbb5fb (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to 11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d0839a2d-35f1-1f14-e053-2995a90ad549 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cbfd9d95-f50b-45ff-9857-9f1712c45e56 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ca619439-f4ca-43f1-9261-9aa2b6dc7450 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9-11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:af2b73da-1be4-4b7f-929b-acb3b9a10f78 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to 11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2ac7d23c-5f9f-4ffc-ae01-d7099a8a7929 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to 11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9cfddd01-6e1d-4ee0-9310-3fb371724e3d (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2b2dcd54-47e0-494b-85d2-c28c3adbe737 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to 11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c8f96b24-de66-4a17-b798-42b42a25e84c (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6e0ade9e-b721-4701-bcb7-de464e19e707 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to 11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:30b4d5c4-0a31-c385-e063-6394a90adbce (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to 11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dcbdb62a-a4e2-4058-b73c-46005f2a5d51 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to11 L/kg and the plasma protein binding is low (45%).
Projected row 936
- Medicine slug
- memantine
- Compared field
- tMax
- Comparison state
- insufficient_context
- Reason codes
- STRUCTURED_CONTEXT_MISSING
- Documents examined
- 67
- Source count
- 67
- Agreement rate
- 0.865672
- Recorded readings
3 to 7 hours
- Numeric value
- 3
- Unit
- hours
- Source records
- 58
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 58 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:421f6478-09df-49d3-a7c4-52814b4aa90e (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration memantine is highly absorbed with peak concentrations reached in about 3 to 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a5dcc0e7-761f-4294-bb48-e5ee4a1e2f67 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration memantine is highly absorbed with peak concentrations reached in about 3 to 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d1f97615-e888-421e-b50a-95a87a1965ff (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
In vitro studies have shown that memantine does not affect the reversible inhibition of acetylcholinesterase by donepezil, galantamine, or tacrine. 12.3 Pharmacokinetics Absorption Following oral administration memantine is highly absorbed with peak concentrations reached in about 3-7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:910827aa-5320-446c-8f66-3f17c0ee36d9 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration memantine is highly absorbed with peak concentrations reached in about 3 to 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5c8a168d-aef5-4ac7-b8c1-3812a8c228ab (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration memantine is highly absorbed with peak concentrations reached in about 3 to 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f73e0df0-4af4-42f1-bde6-3cccb47ca378 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration memantine is highly absorbed with peak concentrations reached in about 3 to 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a7b76864-6de7-45f6-be5b-5ecfca811627 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
In vitro studies have shown that memantine does not affect the reversible inhibition of acetylcholinesterase by donepezil, galantamine, or tacrine. 12.3 Pharmacokinetics Absorption Following oral administration memantine is highly absorbed with peak concentrations reached in about 3-7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:afc07196-be28-4521-afc0-d4aa5b6fd46d (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration memantine is highly absorbed with peak concentrations reached in about 3-7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:72973b46-f307-4a9e-8fb1-ad2cbccfd736 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration memantine is highly absorbed with peak concentrations reached in about 3-7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a71e2482-5266-d03e-8b36-862afe78c9a4 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration memantine is highly absorbed with peak concentrations reached in about 3 to 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:be919d34-e9f4-49c8-8145-2dcafb7cb88c (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration memantine is highly absorbed with peak concentrations reached in about 3 to7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7a40ed9d-8853-b616-ff47-0c7b0fd28959 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration memantine is highly absorbed with peak concentrations reached in about 3 to 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6906b0b4-1944-40f0-844a-e0db72ba4675 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
I n vitro studies have shown that memantine does not affect the reversible inhibition of acetylcholinesterase by donepezil, galantamine, or tacrine. 12.3 Pharmacokinetics Absorption Following oral administration memantine is highly absorbed with peak concentrations reached in about 3 to 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ceb733fa-4526-4b76-ab6a-bd4c5638afff (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration memantine is highly absorbed with peak concentrations reached in about 3 to 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2bd37a6f-bdeb-42c2-9f03-fbf06b45cfe0 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration memantine is highly absorbed with peak concentrations reached in about 3 to7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f05e381f-850d-42ea-9dd8-6d1f8dac4f62 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration memantine is highly absorbed with peak concentrations reached in about 3 to7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9b4e3c54-c001-47cc-bc3a-7d4bf25ccfaf (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration memantine is highly absorbed with peak concentrations reached in about 3 to 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:becb09dc-174d-4817-88d4-f38c8adcd309 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration memantine is highly absorbed with peak concentrations reached in about 3-7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:54a12ddf-306b-4eb7-a7c3-c7b58df3b372 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration memantine is highly absorbed with peak concentrations reached in about 3 to7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:65c9e7bc-71f0-4113-8de1-4fcaa591735f (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration memantine is highly absorbed with peak concentrations reached in about 3 to 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:292671f2-f221-4a3d-a110-a266a9527e04 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration memantine is highly absorbed with peak concentrations reached in about 3-7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3662b11a-354a-b683-e063-6394a90a0086 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration memantine is highly absorbed with peak concentrations reached in about 3 to7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fac8c59b-5bf5-478e-8223-a5ecaa400625 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration memantine is highly absorbed with peak concentrations reached in about 3 to7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4d48c958-b606-4427-8502-53450718eefb (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration memantine is highly absorbed with peak concentrations reached in about 3 to 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:304a3059-4f7f-4ec4-839d-86492bb5e07b (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration memantine is highly absorbed with peak concentrations reached in about 3 to 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e5754973-e73b-4a25-abb4-80f91880f018 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration memantine is highly absorbed with peak concentrations reached in about 3-7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:47e4a696-fe2a-c905-e063-6294a90a7415 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
In vitro studies have shown that memantine does not affect the reversible inhibition of acetylcholinesterase by donepezil, galantamine, or tacrine. 12.3 Pharmacokinetics Absorption Following oral administration memantine is highly absorbed with peak concentrations reached in about 3-7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d1963395-3cf7-4433-bf2c-06295bb1c5b0 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration memantine is highly absorbed with peak concentrations reached in about 3 to 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:66db6d61-cf1d-46ca-a645-19e9a20f4617 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration memantine is highly absorbed with peak concentrations reached in about 3-7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2d54be77-75b2-76b3-e063-6294a90a0cc0 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration memantine is highly absorbed with peak concentrations reached in about 3 to7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d0a5e0fc-04e3-417d-bef3-9b309ff71597 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration memantine is highly absorbed with peak concentrations reached in about 3 to 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1b4a0162-9cb4-4ba6-8c02-95c2955734ae (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration memantine is highly absorbed with peak concentrations reached in about 3 to 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c8f5c20b-4573-44c5-89fc-4da11b2e1fe1 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration memantine is highly absorbed with peak concentrations reached in about 3-7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:42f0a9f2-4aa4-46fb-bc24-d3df843bb906 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration memantine is highly absorbed with peak concentrations reached in about 3 to 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2fdf0b2b-0337-472d-83ec-075c17c9b0d0 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
In vitro studies have shown that memantine does not affect the reversible inhibition of acetylcholinesterase by donepezil, galantamine, or tacrine. 12.3 Pharmacokinetics Absorption Following oral administration memantine is highly absorbed with peak concentrations reached in about 3-7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:054069b5-7aac-4106-821f-ebf7fd531b4f (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration memantine is highly absorbed with peak concentrations reached in about 3 to 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:11d27c75-fdc0-f9da-e063-6394a90ac6b0 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
In vitro studies have shown that memantine does not affect the reversible inhibition of acetylcholinesterase by donepezil, galantamine, or tacrine. 12.3 Pharmacokinetics Absorption Following oral administration memantine is highly absorbed with peak concentrations reached in about 3-7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b86c0f6e-480b-40e7-aa4d-21bd0659101d (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration memantine is highly absorbed with peak concentrations reached in about 3 to 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1289db0e-5179-d157-e063-6294a90ab758 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
In vitro studies have shown that memantine does not affect the reversible inhibition of acetylcholinesterase by donepezil, galantamine, or tacrine. 12.3 Pharmacokinetics Absorption Following oral administration memantine is highly absorbed with peak concentrations reached in about 3-7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bf395152-2885-4633-bf3f-2da46e7b79f1 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration memantine is highly absorbed with peak concentrations reached in about 3 to7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:30b8b982-db74-7cf4-e063-6394a90a3a6b (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration memantine is highly absorbed with peak concentrations reached in about 3-7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:989fa756-7d70-4ea7-bb5e-f4395e48589d (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration memantine is highly absorbed with peak concentrations reached in about 3-7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d1c2ec99-7183-46e3-a96e-4f23e20b8b06 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration memantine is highly absorbed with peak concentrations reached in about 3-7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ff74edcb-d7ed-4b70-8f22-4cb5ccc58f90 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
In vitro studies have shown that memantine does not affect the reversible inhibition of acetylcholinesterase by donepezil, galantamine, or tacrine. 12.3 Pharmacokinetics Absorption Following oral administration memantine is highly absorbed with peak concentrations reached in about 3-7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0ad2246a-ffa0-43a0-8094-58279d3e3a74 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration memantine is highly absorbed with peak concentrations reached in about 3 to7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8bd5b908-f46a-4ced-9408-45984d716149 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration memantine is highly absorbed with peak concentrations reached in about 3 to7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4076d3ef-d0a9-96c5-1a15-812c1e42929c (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration memantine is highly absorbed with peak concentrations reached in about 3 to 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c343b0c5-3bfc-4b94-9483-a56924f6dcdb (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration memantine is highly absorbed with peak concentrations reached in about 3-7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d0839a2d-35f1-1f14-e053-2995a90ad549 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
In vitro studies have shown that memantine does not affect the reversible inhibition of acetylcholinesterase by donepezil, galantamine, or tacrine. 12.3 Pharmacokinetics Absorption Following oral administration memantine is highly absorbed with peak concentrations reached in about 3 to7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cbfd9d95-f50b-45ff-9857-9f1712c45e56 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration memantine is highly absorbed with peak concentrations reached in about 3 to7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ca619439-f4ca-43f1-9261-9aa2b6dc7450 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
In vitro studies have shown that memantine does not affect the reversible inhibition of acetylcholinesterase by donepezil, galantamine, or tacrine. 12.3 Pharmacokinetics Absorption Following oral administration memantine is highly absorbed with peak concentrations reached in about 3-7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:af2b73da-1be4-4b7f-929b-acb3b9a10f78 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration memantine is highly absorbed with peak concentrations reached in about 3 to 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2ac7d23c-5f9f-4ffc-ae01-d7099a8a7929 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration memantine is highly absorbed with peak concentrations reached in about 3 to 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9cfddd01-6e1d-4ee0-9310-3fb371724e3d (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration memantine is highly absorbed with peak concentrations reached in about 3 to7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c8f96b24-de66-4a17-b798-42b42a25e84c (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration memantine is highly absorbed with peak concentrations reached in about 3 to7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6e0ade9e-b721-4701-bcb7-de464e19e707 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration memantine is highly absorbed with peak concentrations reached in about 3 to 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:30b4d5c4-0a31-c385-e063-6394a90adbce (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration memantine is highly absorbed with peak concentrations reached in about 3 to 7 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dcbdb62a-a4e2-4058-b73c-46005f2a5d51 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Following oral administration memantine is highly absorbed with peak concentrations reached in about 3 to7 hours.
18 hours
- Numeric value
- 18
- Unit
- hours
- Source records
- 9
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 9 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:62e32b0b-1eb2-424d-bfd2-d27ef27d35f3 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, peak plasma concentrations are achieved about 18 hours after administration with food versus approximately 25 hours after administration on an empty stomach.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0c7fd6ab-2ce5-4110-b6e6-9103c8da0765 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, peak plasma concentrations are achieved about 18 hours after administration with food versus approximately 25 hours after administration on an empty stomach.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:eac265e6-6ea4-4368-acff-2efe6a8dd40a (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, peak plasma concentrations are achieved about 18 hours after administration with food versus approximately 25 hours after administration on an empty stomach.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:24290655-47f3-4042-a977-a832c5161d2c (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, peak plasma concentrations are achieved about 18 hours after administration with food versus approximately 25 hours after administration on an empty stomach.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a282fbed-8304-458e-a0e9-5eaccc95339b (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, peak plasma concentrations are achieved about 18 hours after administration with food versus approximately 25 hours after administration on an empty stomach.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a74050c4-5a37-4fa1-85d9-85831525cfeb (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, peak plasma concentrations are achieved about 18 hours after administration with food versus approximately 25 hours after administration on an empty stomach.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f2b7538d-8ca1-4ac7-a172-d268e2fa9a52 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, peak plasma concentrations are achieved about 18 hours after administration with food versus approximately 25 hours after administration on an empty stomach.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f6ce7cca-d245-44f2-986c-2a8d85dbb5fb (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, peak plasma concentrations are achieved about 18 hours after administration with food versus approximately 25 hours after administration on an empty stomach.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2b2dcd54-47e0-494b-85d2-c28c3adbe737 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
However, peak plasma concentrations are achieved about 18 hours after administration with food versus approximately 25 hours after administration on an empty stomach.
Projected row 937
- Medicine slug
- memantine
- Compared field
- volumeOfDistribution
- Comparison state
- insufficient_context
- Reason codes
- STRUCTURED_CONTEXT_MISSING
- Documents examined
- 67
- Source count
- 67
- Agreement rate
- 0.985075
- Recorded readings
9 to 11 L/kg
- Numeric value
- 9
- Unit
- L/kg
- Source records
- 66
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 66 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:421f6478-09df-49d3-a7c4-52814b4aa90e (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to 11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a5dcc0e7-761f-4294-bb48-e5ee4a1e2f67 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to 11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:62e32b0b-1eb2-424d-bfd2-d27ef27d35f3 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9-11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d1f97615-e888-421e-b50a-95a87a1965ff (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9-11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:910827aa-5320-446c-8f66-3f17c0ee36d9 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to 11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5c8a168d-aef5-4ac7-b8c1-3812a8c228ab (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to 11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a7b76864-6de7-45f6-be5b-5ecfca811627 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9-11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0c7fd6ab-2ce5-4110-b6e6-9103c8da0765 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9-11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:afc07196-be28-4521-afc0-d4aa5b6fd46d (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9-11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:72973b46-f307-4a9e-8fb1-ad2cbccfd736 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9-11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a71e2482-5266-d03e-8b36-862afe78c9a4 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to 11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:be919d34-e9f4-49c8-8145-2dcafb7cb88c (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7a40ed9d-8853-b616-ff47-0c7b0fd28959 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to 11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6906b0b4-1944-40f0-844a-e0db72ba4675 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to 11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ceb733fa-4526-4b76-ab6a-bd4c5638afff (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to 11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2bd37a6f-bdeb-42c2-9f03-fbf06b45cfe0 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f05e381f-850d-42ea-9dd8-6d1f8dac4f62 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9b4e3c54-c001-47cc-bc3a-7d4bf25ccfaf (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to 11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:becb09dc-174d-4817-88d4-f38c8adcd309 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9-11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:54a12ddf-306b-4eb7-a7c3-c7b58df3b372 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:eac265e6-6ea4-4368-acff-2efe6a8dd40a (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to 11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:24290655-47f3-4042-a977-a832c5161d2c (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to 11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:65c9e7bc-71f0-4113-8de1-4fcaa591735f (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to 11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:292671f2-f221-4a3d-a110-a266a9527e04 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9-11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3662b11a-354a-b683-e063-6394a90a0086 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fac8c59b-5bf5-478e-8223-a5ecaa400625 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4d48c958-b606-4427-8502-53450718eefb (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to 11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:304a3059-4f7f-4ec4-839d-86492bb5e07b (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to 11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e5754973-e73b-4a25-abb4-80f91880f018 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9-11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:47e4a696-fe2a-c905-e063-6294a90a7415 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9-11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d1963395-3cf7-4433-bf2c-06295bb1c5b0 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to 11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:66db6d61-cf1d-46ca-a645-19e9a20f4617 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9-11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2d54be77-75b2-76b3-e063-6294a90a0cc0 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a282fbed-8304-458e-a0e9-5eaccc95339b (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9-11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d0a5e0fc-04e3-417d-bef3-9b309ff71597 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to 11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a74050c4-5a37-4fa1-85d9-85831525cfeb (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to 11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1b4a0162-9cb4-4ba6-8c02-95c2955734ae (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to 11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c8f5c20b-4573-44c5-89fc-4da11b2e1fe1 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9-11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:42f0a9f2-4aa4-46fb-bc24-d3df843bb906 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to 11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2fdf0b2b-0337-472d-83ec-075c17c9b0d0 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9-11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:054069b5-7aac-4106-821f-ebf7fd531b4f (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to 11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:11d27c75-fdc0-f9da-e063-6394a90ac6b0 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9-11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b86c0f6e-480b-40e7-aa4d-21bd0659101d (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to 11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1289db0e-5179-d157-e063-6294a90ab758 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9-11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bf395152-2885-4633-bf3f-2da46e7b79f1 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:30b8b982-db74-7cf4-e063-6394a90a3a6b (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9-11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f2b7538d-8ca1-4ac7-a172-d268e2fa9a52 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to 11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:989fa756-7d70-4ea7-bb5e-f4395e48589d (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9-11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d1c2ec99-7183-46e3-a96e-4f23e20b8b06 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9-11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ff74edcb-d7ed-4b70-8f22-4cb5ccc58f90 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9-11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0ad2246a-ffa0-43a0-8094-58279d3e3a74 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8bd5b908-f46a-4ced-9408-45984d716149 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4076d3ef-d0a9-96c5-1a15-812c1e42929c (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to 11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c343b0c5-3bfc-4b94-9483-a56924f6dcdb (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9-11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f6ce7cca-d245-44f2-986c-2a8d85dbb5fb (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to 11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d0839a2d-35f1-1f14-e053-2995a90ad549 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cbfd9d95-f50b-45ff-9857-9f1712c45e56 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ca619439-f4ca-43f1-9261-9aa2b6dc7450 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9-11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:af2b73da-1be4-4b7f-929b-acb3b9a10f78 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to 11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2ac7d23c-5f9f-4ffc-ae01-d7099a8a7929 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to 11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9cfddd01-6e1d-4ee0-9310-3fb371724e3d (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2b2dcd54-47e0-494b-85d2-c28c3adbe737 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to 11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c8f96b24-de66-4a17-b798-42b42a25e84c (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6e0ade9e-b721-4701-bcb7-de464e19e707 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to 11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:30b4d5c4-0a31-c385-e063-6394a90adbce (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to 11 L/kg and the plasma protein binding is low (45%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dcbdb62a-a4e2-4058-b73c-46005f2a5d51 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 to11 L/kg and the plasma protein binding is low (45%).
9 L/kg
- Numeric value
- 9
- Unit
- L/kg
- Source records
- 1
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 1 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f73e0df0-4af4-42f1-bde6-3cccb47ca378 (opens source in a new tab)
Memantine label
Version not recorded · Effective date not recorded
Distribution The mean volume of distribution of memantine is 9 L/kg to 11 L/kg and the plasma protein binding is low (45%).
Projected row 938
- Medicine slug
- meperidine
- Compared field
- bioavailability
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 5
- Source count
- 3
- Agreement rate
- 1
- Recorded readings
50%
- Numeric value
- 50
- Unit
- %
- Source records
- 3
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 3 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:792fefda-6cc4-4709-b902-fd9787fc310a (opens source in a new tab)
Meperidine label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Oral bioavailability of meperidine is approximately 50%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fae5cc34-5917-4445-9516-25f97ffca8db (opens source in a new tab)
Meperidine label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Oral bioavailability of meperidine is approximately 50%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:15bc51a8-1e24-4d33-9a2f-05a41c29acf0 (opens source in a new tab)
Meperidine label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Oral bioavailability of meperidine is approximately 50%.
Projected row 939
- Medicine slug
- meperidine
- Compared field
- halfLife
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 5
- Source count
- 5
- Agreement rate
- 1
- Recorded readings
3 to 8 hours
- Numeric value
- 3
- Unit
- hours
- Source records
- 5
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 5 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e0e998da-f056-4fce-be8e-ed60cf3b461b (opens source in a new tab)
Meperidine label
Version not recorded · Effective date not recorded
Hepatic Impairment The elimination half-life is 3 to 8 hours in healthy volunteers and is 1.3 to 2 times greater in post-operative or cirrhotic patients.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:792fefda-6cc4-4709-b902-fd9787fc310a (opens source in a new tab)
Meperidine label
Version not recorded · Effective date not recorded
Elimination The elimination half-life is 3 to 8 hours in healthy volunteers.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fae5cc34-5917-4445-9516-25f97ffca8db (opens source in a new tab)
Meperidine label
Version not recorded · Effective date not recorded
Elimination The elimination half-life is 3 to 8 hours in healthy volunteers.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b31d1308-28c3-43f4-e0a6-2f3ed76b8975 (opens source in a new tab)
Meperidine label
Version not recorded · Effective date not recorded
Specific Population Hepatic Impairment The elimination half-life is 3 to 8 hours in healthy volunteers and is 1.3 to 2 times greater in post‑operative or cirrhotic patients.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:15bc51a8-1e24-4d33-9a2f-05a41c29acf0 (opens source in a new tab)
Meperidine label
Version not recorded · Effective date not recorded
Elimination The elimination half-life is 3 to 8 hours in healthy volunteers.
Projected row 940
- Medicine slug
- mercaptopurine
- Compared field
- halfLife
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 6
- Source count
- 3
- Agreement rate
- 1
- Recorded readings
2 hours
- Numeric value
- 2
- Unit
- hours
- Source records
- 3
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 3 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c3b5b8b0-bc5c-4ce9-bbdc-febba60c2658 (opens source in a new tab)
Mercaptopurine label
Version not recorded · Effective date not recorded
Elimination The elimination half-life is less than 2 hours following a single oral dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e7309808-5ae8-4a55-90e3-3992ace0da62 (opens source in a new tab)
Mercaptopurine label
Version not recorded · Effective date not recorded
Elimination The elimination half-life is less than 2 hours following a single oral dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4bae5ffb-a535-3fa0-e063-6294a90aa90a (opens source in a new tab)
Mercaptopurine label
Version not recorded · Effective date not recorded
Elimination The elimination half-life is less than 2 hours following a single oral dose.
Access
Query or download the projection
GET /api/datasets/source-consensus?limit=10&offset=930Allowed query parameters
- q
- Case-insensitive text search over the public fields named for this dataset.
- state
- Exact comparability state.Values: agree, differ, not_comparable, insufficient_context
- field
- Exact recorded field key.Values: bioavailability, halfLife, proteinBinding, tMax, volumeOfDistribution
- limit / offset
- Pagination is required. limit is at most 200; offset is bounded. Set format=csv for the same projected page as a download.
Reuse and corrections
Keep the boundary attached
CC BY 4.0 applies to RNAWiki licenses its selection, schema, structure, and derived projection. Quoted source passages and third-party records retain their original rights.
Cite RNAWiki, this dataset identifier, and the generated date. Keep the “does not mean” statement with any downstream display so a corpus measurement is not mistaken for medical advice.